Genmab | GEN - Marktkapitalisierung

Aktienkurs
1,637.00
Täglich Wechseln
-8.00 -0.49%
Monatlich
-10.67%
Jährlich
20.06%
Q1 Prognose
1,614.31




Marktkapitalisierung Veränderung Datum
Agios Pharmaceuticals USD 1.59B 745M 2025-12
Almirall EUR 2.43B 328.57M 2026-03
Amarin USD 308M 18M 2026-03
Amgen USD 176.25B 24.32B 2025-12
argenx SE USD 35.7B 16.14B 2026-03
AstraZeneca USD 220.14B 68B 2026-03
Bayer EUR 38.45B 2.09B 2026-03
BioMarin Pharmaceutical USD 11.76B 348M 2026-03
Demant DKK 46.01B 10.48B 2025-12
Exelixis USD 11.75B 959M 2025-12
Fresenius Medical Care EUR 11.68B 275.81M 2026-03
Galapagos EUR 1.89B 49.73M 2026-03
Genmab DKK 105.72B 85.24B 2026-03
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
GN Store Nord DKK 16.11B 98.09M 2025-12
GRIFOLS EUR 4.43B 3.06B 2026-03
Hikma Pharmaceutical USD 2.92B 1.72B 2026-03
Insmed USD 37.12B 6.68B 2025-12
Lonza CHF 34.33B 3.44B 2026-03
Merck EUR 47.3B 6B 2026-03
Novartis USD 240.48B 51.73B 2026-03
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.88B 4.46B 2025-12
UCB EUR 47.65B 1.24B 2026-03